Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029）
Clinical trial NCT03743129 · COMPLETED
Trial details
- NCT number
- NCT03743129
- Sponsor
- Anhui Shi, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-12
- Primary completion
- 2021-11-11
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.